NSC-777213

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameNSC-777213
Drug Alias NameNSC-777213
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDual specificity mitogen-activated protein kinase kinase inhibitorsSerine/threonine-protein kinase mTOR inhibitors +[3] 
TargetsDual specificity mitogen-activated protein kinase kinaseSerine/threonine-protein kinase mTORSerine/threonine-protein kinase AKT1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTaipei Medical University
China Registration ClassN/A

Develop Information

Active CompaniesTaipei Medical University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A